Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
193.46B
Market cap193.46B
Price-Earnings ratio
10.51
Price-Earnings ratio10.51
Dividend yield
2.86%
Dividend yield2.86%
Average volume
8.89M
Average volume8.89M
High today
$43.77
High today$43.77
Low today
$43.08
Low today$43.08
Open price
$43.62
Open price$43.62
Volume
6.56M
Volume6.56M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

TipRanks 1h
Novo Nordisk rebranding as ‘Novo,’ announces cultural reset

Novo Nordisk (NVO) is changing its day-to-day name to “Novo” and taking a new approach to company culture, the company said on Monday. The company set out on Mo...

TipRanks 1h
Ascendis Pharma downgraded to Outperform from Strong Buy at Raymond James

Raymond James downgraded Ascendis Pharma (ASND) to Outperform from Strong Buy with an unchanged price target of $287 after the company announced it will regain...

Barron's 15h
Novo Nordisk Is Dropping Some Weight. Can a Rebrand Save the Stock? - Barron's

...

Novo Nordisk Is Dropping Some Weight. Can a Rebrand Save the Stock? - Barron's

More NVO News

TipRanks 20h
Novo Nordisk Kept at Hold as Analyst Maintains $47 Price Target Amid Strategic Uncertainty

BMO Capital analyst Evan Seigerman maintained a Hold rating on Novo Nordisk yesterday and set a price target of $47.00. Evan Seigerman has given his Hold ratin...

MarketWatch 22h
Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars

Novo Nordisk, the Danish drug giant behind Ozempic, is streamlining its corporate culture and shortening its name as it tries to better compete in the market fo...

Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars
The Wall Street Journal 1d
Novo Nordisk to Rebrand as Novo

Novo will be used on a day-to-day basis, while Novo Nordisk A/S will remain it's legal global company name. Tom Little / Reuters Wegovy maker Novo Nordisk NOVO...

Novo Nordisk to Rebrand as Novo
Nasdaq 1d
Novo Nordisk Unveils 'Novo' Name And 'The Novo Way' Culture

(RTTNews) - Novo Nordisk A/S (NVO, NOVO-B.CO), a healthcare company, on Monday announced a rebrand centred on "Lasting Health Starts Now" and the use of "Novo"...

Novo Nordisk Unveils 'Novo' Name And 'The Novo Way' Culture
Nasdaq 2d
Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst

Key Points Novo Nordisk launched its Wegovy pill in early 2026, with Eli Lilly quickly following with a pill called Foundayo. Novo Nordisk's pill has been ver...

Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst
TipRanks 3d
Novo Nordisk Stock Slides as GLP-1 Fears Mount

Novo Nordisk ( (NVO) ) has fallen by -7.58%. Read on to learn why. Novo Nordisk shares fell 7.58% over the past week as investor sentiment weakened on a mix of...

Nasdaq 4d
Could This New Opportunity Be Worth Billions for Novo Nordisk?

Key Points A recent clinical trial win could help Novo Nordisk expand its GLP-1 addressable market. The company is looking to bounce back after multiple setba...

Could This New Opportunity Be Worth Billions for Novo Nordisk?

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.